Akebia Therapeutics
(AKBA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 95,394 | 126,320 | 21,215 | 0 | 0 |
| Marketable Securities | 28,852 | 5,832 | 11,341 | 0 | 0 |
| Receivables | 114 | 119 | 135 | 0 | 0 |
| TOTAL | $126,051 | $133,739 | $33,431 | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 181 | 164,204 | 30 | N/A | N/A |
| Other Non-Current Assets | 125 | 125 | 1,204 | 0 | 0 |
| TOTAL | $306 | $164,329 | $1,234 | $N/A | $N/A |
| Total Assets | $126,358 | $134,028 | $34,665 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,488 | 2,077 | 714 | 0 | 0 |
| Accrued Expenses | 3,278 | 4,042 | 3,188 | 0 | 0 |
| TOTAL | $4,770 | $6,123 | $3,902 | $0 | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 30 | 30 | 8 | 0 | 0 |
| TOTAL | $36 | $38 | $8 | $N/A | $N/A |
| Total Liabilities | $4,806 | $6,161 | $3,910 | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 20,263 | 20,262 | N/A | N/A | N/A |
| Retained earnings | -80,955 | -73,336 | -127,072 | 0 | 0 |
| Other shareholders' equity | -30 | 0 | 157,827 | 0 | 0 |
| TOTAL | $121,552 | $127,867 | $30,755 | $0 | $0 |
| Total Liabilities And Equity | $126,358 | $134,028 | $34,665 | $0 | $0 |